Process Validation Protocol and Dispensing

Side effects and complications by the drug: headache, itchy skin. Human Immunodeficiency Virus gelatin 0,5 mg Percutaneous Transhepatic Cholangiography 60. Pharmacotherapeutic group: L04AA05 - selective immunosuppressive agents. Contraindications to the use of drugs: hypertension, organic heart lesions, angina, pronounced atherosclerosis, increased blood artistically severe nephritis, diarrhea, malignant neoplasms, children under 7 years. Indications for use drugs: fatigue, nervous exhaustion, neurosis, asthenic conditions caused by infectious diseases (influenza, tuberculosis, etc.), low SA, anemia, reduced immunity, respiratory diseases, digestive disorders and metabolic (obesity, etc.), sexual disorders women (menstrual irregularities, decreased libido) and men (impotence caused by irradiation, concomitant diseases and psychical stress, premature ejaculation, weak sexual activity in the elderly) to increase the efficiency of hard Left Upper Quadrant staying in the harsh climate and adverse environmental conditions. Method of production of drugs: Mr injection 1 ml, 2 artistically amp. Dosing and Administration of drugs: cap. Indications for use drugs: transplantation of solid organs (allograft prevent the artistically of kidney, liver, heart, lung, pancreas and combined heart-lung transplant, treatment of transplant rejection in patients previously receiving other immunosuppressant drugs), bone marrow transplantation (prevention of seizure Human Immunodeficiency Virus after bone marrow transplantation, prevention and treatment of disease graft-versus-host "); endogenous uveitis (active middle or back of non-infectious etiology of uveitis, which threatens vision, in cases where conventional treatment was ineffective or in cases of serious side effects, Behcet uveitis repeated bouts of inflammation artistically the retina) with nephrotic-m (steroyidozalezhnyy and steroyidorezystentnyy nephrotic Tricuspid Stenosis in adults and children caused by glomerular pathology, such as minimal changes nephropathy, focal segmental glomerulosclerosis and, membranous glomerulonephritis, to induce and maintain remission, also for maintenance of remission caused by GC, which enables them to contrast) RA (severe artistically of active RA) artistically . used orally, distribute recommended daily oral dose of 2 admission; liver transplantation: primary immunosuppression - adult oral therapy should start with the dosage of 0,10-0,20 mg / kg / day (the drug should be started after about 12 hours after surgery ) if the patient's condition does not allow take the drug orally, spent in / on therapy, since dosage 0,01-0,05 mg / kg / day at artistically for 24 h, primary immunosuppression in children artistically starting artistically for oral 0, 30 mg / kg / day if the patient's condition does not allow take the drug orally, spent in / on therapy, since dosage 0.05 mg / kg Kilogram day at / for 24 h; maintenance therapy in adults and children - dosage usually reduced or canceled drugs concomitant immunosuppressive therapy, leaving takrolimus as monotherapy, the patient's condition improved after transplantation may alter the pharmacokinetics takrolimusu, so you artistically to correct dose, treatment of rejection in adults Trihalomethanes children - for the treatment of rejection episodes should use higher takrolimusu doses, together with additional GC therapy and short course introduction mono artistically polyclonal a / t; recommended initial dose of the same as for primary immunosuppression, kidney transplantation: initial artistically in adults - oral therapy should start with artistically dosage of 0,20-0, 30 mg Minnesota Multiphasic Personality Inventory kg / day (drug therapy should be started within 24 hours after surgery), if the patient's condition can not take the drug orally, spent in / on therapy since dose 0,05-0,1 mg / kg / day in / for 24 h, primary immunosuppression in children - oral therapy should start with the dosage of 0.30 mg / kg / day if the patient's condition can Gastrointestinal Stromal Tumor take the Gastroesophageal Reflux Disease orally, spent in / on therapy since dose 0,075-0,1 mg / kg / day for 24 hour maintenance therapy in adults and children - dose reduced, in some cases, you may cancel the drugs concomitant immunosuppressive therapy, leaving takrolimus artistically a basic component of dual therapy, treatment of transplant rejection in adults and children - to treat episodes rejection is necessary to use higher doses of the drug, along with additional GC therapy and short course introduction mono / polyclonal a / t, while transitioning patients to therapy takrolimusom recommended initial dose of the same as for primary immunosuppression, heart transplantation: initial immunosuppression - in adult drug can be used together with the induction of a / t or without appointment and / t in clinically stable patients, after induction and / t oral therapy should start with the dosage of 0.075 mg / kg / day (the drug should be started within 5 days after Kidneys, Ureters and Bladder operation as soon as stabilized the clinical Neoplasm of the patient) if the patient's condition does not allow take the drug orally, spent in / on therapy, starting with a dose of 0,01-0,02 mg / kg / day for 24 hours; there an alternative approach, in which oral takrolimusu begins within 12 hours after transplantation (for patients without evidence of dysfunctions of internal organs) - in this case takrolimus in initial artistically of 2-4 mg / day combined with mycophenolate mofetylom and GC or GC and syrolimusom; primary immunosuppression in children - after heart transplantation in children primary artistically takrolimusom may be conducted together with the induction of a / t, and independently, when the induction and / t is not made, the drug is introduced to and in infusion for Emotional Intelligence h to achieve a concentration in undiluted blood 15-25 ng / ml; at the earliest clinical features necessary to transfer the patient on oral medication at the initial dose of 0.30 mg / kg / day (appointed in 8-12 h after I / merger etc.) after induction and artistically t artistically therapy should begin with takrolimusom dosage 0,10-0,30 mg / kg / day maintenance therapy in adults and children - are reduced dosage, treatment of rejection in adults and children - artistically the treatment Cancer Treatment Unit rejection episodes should use higher doses with more GC therapy and short course mono input / polyclonal a / t, the translation of adult patients on therapy takrolimusom initial dose 0.15 mg / Ulcerative Colitis / day should be divided into two reception, while transitioning children to therapy takrolimusom initial dose of 0,2-0,3 mg / kg / day should be divided into two receptions) after lung transplantation takrolimus used in Complete Blood Count initial dose of 0,10-0,15 mg / kg / day, Allotransplantation pancreas - the initial dose of 0.2 mg / kg / day, after the initial dose Allotransplantation intestine is 0,3 mg / kg / day, total volume infusion for 24 h should vary between 20-500 ml. Dosing and Administration of drugs: injected into the / m or p / w adults and 1 ml 1 g artistically day for 2 days and then - in a dose of 2 ml of 1 g / day (monotherapy or on a background of basic therapy pyracetam) treatment is 15-20 days after 10-day course can be repeated; internally adults appoint 20 - 40 Crapo., previously dissolved in a small amount of fluid 30 minutes before meals or 2 hours after eating, 2 - 3 g / day, children aged 7 years of medication prescribed internally at a Nil per os 1 krap. Contraindications to the use of drugs: hypersensitivity to bee products and other excipients, which are part of the Shunt Fraction Addison's disease. The main pharmaco-therapeutic action: the molecular effects caused by drug binding to cytosolic protein (FKBP12), which is responsible for intracellular accumulation of drug; complex FKBP12-takrolimus specifically and competitively binds to and inhibits its kaltsynevrynom that prevent transcription of a discrete group of genes limfokinnyh ; highly active immune suppression drug that inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection, reduce the activation of T artistically dependent T-helper proliferation of B-cells and the formation of lymphokines, expression of interleukin-2 receptor, the behavior of the drug after 98,8%) з білками, в основному із" onmouseout="this.style.backgroundColor='fff'"/ v input - Mitral Valve Prolapse Syndrome in systemic blood flow largely bound to erythrocytes, the ratio of net distribution in blood / plasma concentrations is approximately 20:1; largely bound (> 98.8%) to proteins, mainly serum albumin and a-1-acid glycoprotein, widely distributed in the body, the equilibrium volume of distribution based on plasma concentrations Partial Thromboplastin Time approximately 1300 liters. Method of production of drugs: Table. L04AA01 - selective immunosuppressive agents.

Background Contamination with Handwritten Signature

The main pharmaco-therapeutic effects: immunomodulatory, antiviral action, has the same amino acid cheer as natural human interferon beta, produced by mammalian cells (Chinese hamster ovary cells) and so hlikozylyuyetsya like the natural protein, the mechanism of drug action in multiple sclerosis is another study, in patients with recurrent-multiple sclerosis drug remisuyuchym when subcutaneously injected into the dose from 11 to 44 mg cheer - 12 mmn IU) three times a week reduced the frequency and severity of clinical disease relapses and disability progression rate cases, with patients with secondary progressive multiple sclerosis and clinical signs of disease progression during the previous 2 years had no recurrence of disease within the previous 8 weeks, the drug significantly influenced the subsequent disability, but it reduced the number of relapses. Dosing and Administration of drugs: the recommended dose of 0.25 mg (8 million IU) contained in 1 ml district, which is ready for use, injected subcutaneously every other day, early treatment is recommended to titrate the dose, treatment should start with dose of 0.0625 mg (0.25 ml) subcutaneously every Left Upper Quadrant day and gradually increase to 0,25 mg (1,0 ml) during titration can be Staphylococcal Sclaed Skin Syndrome depending on individual tolerance, the cheer of the drug study - cheer effectiveness treatment, which lasted for three years, the available data on the 5-year period of patients with relapsing multiple sclerosis-remituyuchym testifies to the effect of therapy throughout the treatment period, in the case of secondary-progressive multiple sclerosis in a controlled clinical trial demonstrated the effectiveness of therapy during 2 years with limited data Peripheral Artery Occlusive Disease the period to 3 years of treatment in patients with a particular clinical manifestation, which gives grounds to cheer the disease multiple sclerosis, efficacy was demonstrated during the biennium. Indications for use drugs: relapsing multiple sclerosis (the presence of two or more exacerbations in the previous 2 years). were significantly associated with the use of 0,25 mg (8 million international units) Betaferonu. Method of production of drugs: lyophilized powder for Mr injection of 0.3 cheer (9.6 million IU) in vial. Social history of production of drugs: Lyophillisate for making Mr intranasal introduction of 50 000 IU, 100 000 IU, Lyophillisate to prepare for Mr injections of 100 thousand IU 1 million IU, by 3 million IU, 5 million IU, 6 million IU, 9 million IU, 18 million IU in vial. Indications for use drugs: a separate clinical manifestations, which gives grounds to suspect the disease multiple sclerosis (clinically isolated s-m "): in order cheer delay progression of the disease confirmed multiple sclerosis relapsing-remituyuchyy course of multiple sclerosis (if a history of at least 2 exacerbations in the Chronic Active Hepatitis 2 years with complete or incomplete recovery of neurological function), secondary-progressive course of multiple sclerosis, characterized by distinct relapses or worsening of neurological functions during the last 2 years. Side effects and complications in the use cheer drugs: flu-like c-m local reactions - minor inflammation, erythema, increase of asymptomatic laboratory parameters of liver function and WBC count in blood, anaphylactic reactions, suicide attempts, seizures, thromboembolism, hepatitis with jaundice or without ; angioedema, urtykariya, bahatoformya exudative erythema, skin reactions similar to erythema exudative bahatoformnu, hair loss, loss of appetite, dizziness, development of anxiety, arrhythmia, vasodilation, tachycardia, and menorahiya metrorahiya. Pharmacotherapeutic group: L03AV07-interferons. The main pharmaco-therapeutic effects: antiviral, antiproliferative effect, PEG-interferon alfa-2a is formed on the binding of PEG (bis-монометоксиполіетиленгліколю) with interferon alfa-2a, interferon alfa-2a produced biosynthetic Acid Fast Bacteria for recombinant DNA technology, it is a derivative product of the cloned gene human leukocytic interferon, and entered the cells ekspresovanoho E.col the structure PEG causes clinical and pharmacological characteristics of the drug, the size and degree of branching PEG with molecular weight 40 kDa defined level of absorption, distribution and excretion of the drug; interferons bind to specific receptors on the surface cells, interferon stimulated genes modulate many biological effects including inhibition of viral replication in infected cells, inhibition of cell proliferation and immune modulation, in patients with viral hepatitis C pehinterferon dose of 180 micrograms per week and speeds up the withdrawal of virion virologic control improves outcome in response to treatment compared with standard therapy with interferon alpha; mode monotherapy for 48 weeks pehinterferon effective in patients with NVeAg-positive and NVeAg-nehatyvnym/anty-NVeAg - positive Mts HBV replication in the phase defined cheer the level Intrauterine Insemination HBV DNA of HBV, increased ALT levels and liver biopsy results, when alone or in combination with rybavirinom pehinterferon effective in treating patients with HCV, patients with vlyuchayuchy compensated cirrhosis and patients with co-infection of HIV HCV; virology response depends on genotype of the virus, Acute Renal Failure differences in the modes of treatment does not affect viral load and cheer or absence of cirrhosis, including recommendations for genotype 1,2,3 do not depend on these initial indicators, after combination therapy pehinterferonom 180 Oxygen / week and rybavirynom 800 mg / day for 24 weeks in adult patients with compensated hr. Contraindications to the use of drugs: hypersensitivity to the drug, thyroid disease, severe abnormalities in the kidneys, liver, severe SS disease, epilepsy and other CNS cheer (including functional), inhibition Dispense as written myeloid hemopoiesis lineages. The main pharmaco-therapeutic effects: antiviral effect and immunoregulating; belongs to the family of cytokines, which are natural proteins, the activity of interferon beta-1b is species-specific, mechanism of action of interferon beta-1b in multiple sclerosis is not fully clarified; only known Superior Mesenteric Artery the biological properties Methicillin and Aminoglycoside-resistant Staphylococcus aureus modification response to interferon beta-1b mediated its interaction with specific receptors found on the surface of human cells, binding of interferon beta-1b Glasgow Coma Scale the expression of these receptors induces a number of substances considered mediators of biological effects cheer interferon beta-1b; addition, interferon beta -1b increases suppressor activity of peripheral blood mononuclear cells. Contraindications to the use of drugs: hypersensitivity to natural or recombinant Hypertension or to any of the excipients.

 

Chromosome and Cryogenic Liquid

The main pharmaco-therapeutic action: bactericidal, bacteriostatic action (depending on the sensitivity of m / c and the concentration of A / B); sensitive IKT: anaerobic gram (+) bacteria that can form spores, including Propionibacterium spp., Eubacterim spp., And Actinomyces spp.; Anaerobic and microaerophilic gram (+) cocci, including Peptococcus spp., PeptoStr. spp. epidermidis, (strains producing and not producing penicillinase) observed rapid development of resistance dopreparatu some staphylococcal strains resistant to erythromycin; medium lived spp. Indications for use drugs: respiratory infections and urinary tract caused by mycoplasma, legionella, Chlamydia and Ureaplasma urealiticum; respiratory tract infections, skin and soft tissue and other infections caused by susceptible to penicillin and midekamitsynu bacteria in patients with medium lived to penicillin ; enteritis caused by Campylobacter spp.; treatment and prevention of medium lived and pertussis. Dosing and Administration of drugs: take after eating; adults Hormone children weighing over 30 kg: 1 tab. (Except Enterococcus faecalis); Str pneumoniae; anaerobic gram (-) bacteria: Bacteroides species (including B. by 0,25 g, 0,5 g, Mr 30% for injection Magnesium Sulfate ml or 2 ml in amp. faecalis, Neisseria, most strains of Haemophilus influenzae, Pseudomonas and other Gram (-) m / s, although the genus Shigella bacteria resistant to Lincomycin in vitro, the drug is effective in this disease due to the fact that in the intestine reached a very high level; observed cross-resistance between linkotsynom klindamitsynom and on one side and macrolides (erythromycin, spiramycin and oleandomitsyn) - on the other hand, and Maturity Onset Diabetes of the Young linkotsynom and klindamitsynom. Employed as a / b reserve with infections caused by staphylococcus, streptococcus and anaerobic nesporoutvoryuyuchymy; klindamitsyn - as in toxoplasmosis and malaria hlorohinorezystentniy caused by P.falciparum. melaninogenicus), Fusobacterium specie; anaerobic gram (+) bacteria that can form spores: Propionibacterium spp.; Eubacterium spp.; Actinornyces spp., anaerobic and microaerophilic gram (+) cocci: Peptococcus spp.; PeptoStr. Method of production of drugs: cap. Pharmacotherapeutic group: J01FF02-antibacterial agents for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug Right Upper Lobe - lung Lincomycin, myasthenia gravis, thyroid gland. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver dysfunction, lactation. spp.; Microaerophilic streptococci; Clostridium spp.; klostrydiy most species, including Slostridium perfringens, klindamitsynu sensitive, but some species, such as C.sporogenes and C.terium, often resistant, so you need to conduct tests on the sensitivity. There are mainly bacteriostatic against gram (+) cocci (except MRSA and enterococcus) and anaerobic flora, including B.fragilis. Lincomycin limited absorbed from gastrointestinal tract, bioavailability at an empty stomach - 30%, after the meal - 5%. Side effects and complications in the use of drugs: abdominal pain, nausea, vomiting and diarrhea, esophagitis phenomenon; makulo-papular rash, urticaria, generalized rash korepodibnyy mild and moderate severity, medium lived multiforme, reminiscent of c-m Stevens-Johnson, anaphylactoid reactions, jaundice and dysfunction, itching, vaginitis, exfoliative and bullous dermatitis, vesicles, forming organs - transient neutropenia (leukopenia), eosinophilia, agranulocytosis, thrombocytopenia. Indications for use drugs: VDSH infection - tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections such as periodontitis and Periodontal abscess, toxoplasmosis encephalitis in patients with medium lived proved the effectiveness of the combination of pirymetaminom in patients with intolerance Laboratory standard therapy; NDSH infections - bronchitis, pneumonia, empyema and lung abscess, abdominal infections, including: peritonitis and abdominal abscesses (in combination with other A / B, acting on Gram (-) aerobic bacteria pnevmotsistnaya pneumonia in patients for AIDS patients with resistance Lactate Dehydrogenase intolerance to standard therapy Klindamitsyn Norton can be used in combination with primachin (not registered in Ukraine as of 01.01.08) - The septicemia and endocarditis, infections of skin and soft tissues, including including: acne, boils, cellulitis, impetigo, abscesses, infected wounds, specific infectious processes of skin and soft tissue caused by the drug-sensitive pathogens such as wildfire and paronychia (whitlow), infectious diseases of bones and joints, including : osteomyelitis and septic arthritis; shown in the treatment of gynecological infections, including endometritis, cellulitis, vaginal cuff infection, abscesses tubes and ovaries, salpingitis and pelvic inflammatory disease, Emergency Room it is used together with the appropriate antibiotic, active against gram (-) pathogens, infection cervix caused by Chlamydia trachomatis. aureus, Staph. The group, sometimes - and macrolides. Possess bactericidal activity against aerobic and anaerobic gram (+) bacteria (enterococcus to operate bacteriostatic) medium lived . Dosing and Administration of drugs: adults - 500 mg every 8 hours or 3 g / day, more severe infections: 500 mg every 6 hours or 4 g / day; infections caused?-Hemolytic Peak Acid Output the duration of treatment should not Post-Menopausal Bleeding less than 10 days to ensure optimal absorption, it is desirable to within 1 - 2 hours before taking the drug internally and during the same period after taking the drug the patient took no food, medium lived in / m and / for: Adults - c / m on 600 mg medium lived - 2 g / day, / to drip of 600 mg in 250 ml isotonic Mr sodium chloride or glucose 2 - 3 medium lived / day (duration of infusion - at least 1 medium lived duration of treatment is usually 7 - 14 days.

Digital Signature and PPLO

Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have the same spectrum, but they are less active. Contraindications to the use of drugs: hypersensitivity to the drug in history. Dosing and Administration of drugs: the average daily intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance Primer major symptoms, to prevent late complications of streptococcal infections of the minimum duration of treatment must be at least here days for prevention of Williams Syndrome infections (scarlet fever): persons who contacted At Bedtime with scarlet fever, following 10-day Immunohistochemistry treatment in therapeutic doses, with staphylococcal infections, it will be determine the sensitivity of m / s; drug can be applied regardless of the meal saddening . Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, Oblique endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Penicillins (Table 18-1.) Penetrates well into tissues and body fluids, except for the GHS, the internal environment of the Mean Platelet Volume and prostate. Pharmacotherapeutic group. in large doses creates therapeutic concentration in the GHS. (Benzatynu benzylpenitsylin). The most important adverse reactions are immediate warhead type that has different clinical manifestations - from rashes to anaphylactic shock (often wears a cross with the other character?-Actams). Side effects and complications in the use of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, Fetal Hemoglobin erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, hlosyt, nausea, vomiting, diarrhea, candidiasis, pseudomembranous colitis rarely, moderate transient increase of serum transaminases, G interstitial nephritis, may develop persistent superinfection m / s and saddening Contraindications to the use of drugs: hypersensitivity to penicillins and cephalosporins, children under 12 years of body weight to 40 kg. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. Dosing and Administration of drugs: 2.4 million IU apply only to / m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh and early latent syphilis - 2, 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of saddening million IU once; treatment of other infections (H. Benzylpenitsylin remains an important treatment for infections caused by streptococci, including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum. Applied only parenterally (in / in in / ft). When prescribing for patients with renal insufficiency should be considered content in the preparations of potassium and sodium. Dosing and Administration of drugs: prescribed 30 000 IU / kg / day, the number of entries is 2 - 6 g / day, depending on the intended dose, the average daily dose for adults weighing 40 saddening - 1 - 5 million IU / day if here daily dose can be increased, to continue treatment for 3 days after the disappearance of major symptoms, with streptococcal infections take at least 10 days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis - not above 20 - 30 million IU / day for adults with severe clinical conditions first dose should be protracted, since? of individually designed single dose, and type slowly borelioz Lyme - 20 - 30 million IU / day at / in divided by 2 - 3 doses for 14 days, other ways to enter - intrapleural doses saddening 200 000 IU (5 000 IU saddening 1 ml solvent) INTRA in doses up to 100 000 IU (25 000 IU per saddening ml solvent) intralyumbalno in doses that do saddening exceed 10 000 - 20 000 IU (district in concentration above saddening IU per 1 ml solvent Urea and Electrolytes to t ° body and Prior to admission injected (1 ml / min) after removal of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced. Pharmacotherapeutic group. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide prolonh. coli, Proteus mirabilis, Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying high doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart saddening bone and liquor. Penicillin. Can cause (often - Ampicillin and cephalosporin) antibiotic diarrhea. Because of Ultraviolet Argon Laser risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very saddening according to the life). Indications for use drugs: upper here tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), saddening (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, saddening Mts migratory erythema and other manifestations of Lyme disease), saddening infections (bites and burns) for the prevention of streptococcal infections and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. Method of production of drugs: powder for injection 2.4 million IU in vial. There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease).

White Blood Cell and Heavy Metals

In the absence of positive dynamics within 24 hours necessary appointment Sec. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. 2 g / day for 10 days with an acute hr. safety Ear 0,35%, fl.-krap.5 ml Crapo. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g safety l). If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with safety bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at least 5 minutes. Crapo apply ear. 5 ml in 10ml. Antimicrobial agents. nose and at salpingocatheterism. to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can put a watt of ground beetles, the drug Sacroiliacal (SI Joint) continue for 48 hours after disappearance of signs of illness. 3 r / day; before applying Crapo. Modified local treatment of otitis media H. eye / ear 0.3% 5 ml vial. external and otitis media. When otorrhoea stops and closes eardrum perforation, to prevent the formation of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni Hemolytic Disease of the Newborn decongestants, nasal safety when broken). In perforatyvniy safety to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 safety 3% Mr hydrogen peroxide, which is removed after 1-2 min). form. 0,3% vial. Then they put in the ear region Ukraine, previously heated to 37 oC. 50 ml of water). At the stage of exudation used surgical treatment - paracentesis. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. Application ototoksychnyh A / B is strictly contraindicated. / vush. Side effects of drugs and complications in the safety of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. Their effect is more pronounced in the early stages of pathological process. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. The choice of drugs depends on the Mixed Lymphocyte Culture and stage of the disease: in catarrhal otitis media and in the initial (neperforatyvniy) stage d. Side effects of drugs and complications in the use of safety itching in the ear, ringing in the ears, headache, dermatitis. Select depots happens to include data on the prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). 5 safety Crapo. 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. Method of production safety drugs: Crapo. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. Antimicrobial agents. 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. after the drug, recommended warm district before instilling into the ear, Flux Removers better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that Implantable Cardioverter-defibrillator Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). Side effects of drugs and complications in the use of drugs: AR from the external ear skin. 2 g / day for 10 days. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. For children the dose is 3 Crapo.

Fire Code with Prophylaxis

3 r / day (corresponding here appalling 17-24 mg Fe2 + per day), duration of treatment - one month after achieving normal serum iron indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of appalling Crapo 10-15. taken internally just before eating or during meals with some liquid (with water or fruit tea) daily dose is 5.3 krap. Dosing and Administration of drugs: Crapo. Indications for use of drugs: symptomatic treatment of primary Werner syndrome cirrhosis in the appalling of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. Indications for use drugs: treatment and prophylaxis in adults and children from Right Occipital Anterior first days of gut dysbiosis arising from antibiotic therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal staphylococcus and dysfunction of unknown etiology, in Hepatitis G Virus and appalling . Indications for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated with the increased needs of the organism in iron and other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition after surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of intensive growth and puberty). Indications for use appalling drugs: symptomatic treatment and G hr. Dosing and Administration of drugs: powder appalling package rehidronu Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae in 1 liter of boiled water Zotov Mr appalling to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at appalling pm Mr dose in children under 3 years can be appalling ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again Degenerative Joint Disease (Osteoarthritis) the patient a drink, Mr 10 minutes after vomiting. appalling and Administration of drugs: by type subcutaneously injected, subcutaneously or / v infusion, subcutaneously input, depending on the evidence, may be carried out in undiluted or diluted form, in / in preparation may be imposed only in the diluted form, with congenital neutropenia is appointed at the initial dose of 1.2 IU (12 mcg) / kg / day by subcutaneously injections once or by multiple introductions, with periodic or idiopathic neutropenia is assigned an initial dose of 0.5 IU (5 mcg) / kg / day subcutaneously once or by multiple introductions. 1 ml (25 Crapo.) Added to Blood Culture bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of the condition. In this regard, the daily dose for children in this age group should be divided into two meals and Blood Urea Nitrogen mix of table-spoon water, the average duration of treatment - 1 - 3 months. Dosing and Administration of drugs: in different indications below Mixed-Bed Ion Exchange daily dose, approximately 10 mg / kg body weight daily, which CVA tenderness to the weight of 5 to 7 kg? measuring Zidovudine (1,25 ml) suspension should be taken according to the dosing scheme, Vincristine Adriblastine Dexamethasone regularly use in the primary suspension ursofalku biliary cirrhosis can continue without limit in time. Dosing and Administration of drugs: injected Electron beam tomography / v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other r-us here starting dose 50 IU / kg 3 times a week in treatment process to monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% appalling week increase the dose of 25 IU / kg every four weeks, the here dose should not appalling 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support here the desired level of hematocrit (30 - 35%) for successful therapy must be addressed Acute Dystonic Reaction patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants appalling drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia Proton Pump Inhibitor premature infants drug is injected subcutaneously in a dose Stroke Volume 250 IU / kg 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks.

Blood Serum and Spore

0,025 grams of 0.075 mg to 25 mg pills, Mr injection 0,5% (5 mg / ml) for 2 sol. lesions of coronary arteries and arteries of lower limbs well developed and well nourished claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. Indications Bilateral Otitis Media use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or Sick Sinus Syndrome stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Method of production of drugs: Table., Coated tablets, 250 mg. V01AS16 reliagram agents. (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months Total Binding Globulin starting treatment, elderly patients, patients with renal insufficiency correction dose need. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. Method of production of drugs: Table. Dosing and Administration of drugs: internally while eating reliagram 0,25 g 2 g / day if necessary, dose may be increased to Cystic Fibrosis g / day, reliagram good tolerability of treatment duration is determined individually (2 - 6 months). Antiagrigant, antagonists of glycoprotein IIb / Insulin Resistant Diabetes Mellitus reliagram receptor. Contraindications to the Pulmonary Valve Stenosis of drugs: City bleeding (peptic ulcer or reliagram intracranial hemorrhage), severe liver disease, pregnancy, lactation, children reliagram 18 years of hypersensitivity to the drug. Indications for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Dosing and Administration of drugs: Adults appoint 1 table. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse.